The Estée Lauder Companies announced it will explore using biotechnology company Serpin Pharma’s anti-inflammatory research for cosmetic formulations related to the longevity trend. In the exclusive partnership, the companies will investigate how Serpin Pharma’s technology, which leverages the body’s innate immune response, can be harnessed to address skin irritation, aging, and sensitivity. The luxury beauty company will use this research for product innovation.
